FT Health Discusses Life Science Industrial Strategy, Features Interview With Michael Bloomberg

FT Health: Life science strategy needs funding
The latest issue of the Financial Times’ weekly global health newsletter discusses the U.K.’s newly unveiled Life Science Industrial Strategy, which is “the first in a series of government-backed efforts to formulate a new industrial strategy for post-Brexit Britain,” highlighting the need for closer collaboration between industry and the National Health Service. The newsletter also features excerpts from an interview with Michael Bloomberg on non-communicable diseases, as well as a roundup of other global health-related news stories (Cookson, 9/1).